Post
8) Ponting highlights that with evidence on rare mutations, we're much more likely to persuade pharmaceutical companies to invest in drug development. Because studies have shown that with that type of evidence, their investments are more likely to succeed.
0 reposts10 likes
10) Link to the interview: www.youtube.com/watc... More info about the SequenceME & Long Covid project can be found here, including how to donate to it: www.actionforme.org....
youtube.comInterview with Professor Chris Ponting about Sequence ME & Long COVIDLast year’s release of the results from the DecodeME, a UK-based genome wide association study of more than 15,000 DNA samples, generated significant excitement. Action for ME, which spearheaded DecodeME, recently announced that it had received funding for a multi-phase follow-up project called Sequ
This is incredible! Hopefully the Austrian ME/CFS biobank (Medical University Vienna) can send samples for the next round. @kathrynhoffmann.bsky.social